Siemens and Optovent Sign Letter of Intent; Final Agreement to be Signed By End of Year


TABY, Sweden, June 28, 2002 (PRIMEZONE) -- Optovent AB announces the signing of a letter of intent with the Electromedical Systems Division of Siemens Medical Solutions, Inc. to provide Siemens with Optovent FORE technology for respiratory monitoring. Siemens is presently evaluating Optovent FORE technology for integration into its future product development.

"We see this agreement as a testament to the quality and power of our technology," said Christer Jacobsson, CEO of Optovent. "Our future in the American market looks bright; this agreement is a milestone in our continued growth and success."

The letter indicates an intention to sign a final agreement before the end of the year. Siemens anticipates the agreement will enhance its ability to provide powerful solutions to the critical care market. Siemens Medical Solutions of Siemens AG (NYSE:SI) with headquarters in Iselin, NJ and Erlangen, Germany, is one of the largest suppliers to the healthcare industry in the world. The company is renowned for its innovative products, including imaging systems for diagnosis, therapy equipment for treatment, hearing instruments, and critical care and life support systems, as well as a wide array of information technology and data management solutions that optimize workflow and increase efficiency in hospitals, clinics and doctors' offices. The company is known as the premiere health information application service provider processing more than 116 million transactions daily and managing more than 67 terabytes of data - twice the information volume of the Library of Congress. Employing approximately 30.000 people worldwide, the company reported sales of 7.2 billion EUR, orders of 8.4 billion EUR and EBITA of 808 million EUR in fiscal 2001 (September, 30). More information can be obtained by visiting us on the Web at

Siemens AG, headquartered in Munich, is a leading global electronics and engineering Company. It employs some 450,000 in 193 countries, and reported worldwide sales of more than $74 billion in fiscal 2001 (10/1/00 - 9/30/01). The United States is Siemens' largest market, with nearly 80,000 employees and sales of $18.9 billion for fiscal 2001. For more information about Siemens in the u.s., visit

Optovent AB is a Swedish medical technology company, which produces and markets monitoring systems and technology platforms for safe and cost- efficient patient monitoring. The company has developed a proprietary technology for respiratory and apnea monitoring, RtR FORE. The technology has several applications in post-operative care as well as patient monitoring during sedation, patient transportation, and other clinical conditions. It is also used as a diagnostic aid during cardiopulmonary evaluations. Shares of Optovent AB (publ) are publicly traded on the Stockholm New Market Exchange (Nya Marknaden, OM Stockholmsborsen). Fore more information about Optovent, visit

This information was brought to you by Waymaker

The following files are available for download:


Contact Data